Can we incorporate MRD assessment into clinical practice in AML?

Ossenkoppele, G; Schuurhuis, GJ; van de Loosdrecht, A; Cloos, J

Ossenkoppele, G (reprint author), Univ Amsterdam, Med Ctr, Locat VUMC, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019; 32 (2): 186

Abstract

Measurable residual disease (MRD) can be assessed either by flow cytometry or molecular techniques. It has been proven to be highly prognostic in quit......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索